22 February 2018
News and Views
Links and Services
The latest Alimentary Pharmacology & Therapeutics studied prognostic factors for real-life long-term efficacy of infliximab in Crohn's disease.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors